Pharmaceutical Product Development acquired the clinical research site business of Bioclinica.

Pharmaceutical Product Development, a leading global contract research organization, acquired the clinical research site business of Bioclinica, a global life science provider. Financial terms were not disclosed. David Herron, president and CEO of Bioclinica, said, “We believe PPD’s AES business unit is an outstanding strategic fit for the global site business. Both organizations have long been committed to clinical research and together they will provide excellent value for sponsors and CROs. This transaction enables AES to take patient access and site conduct to a new level, while enabling Bioclinica to accelerate its delivery of exceptional services in medical imaging, cardiovascular safety, eClinical and trial software, and drug safety solutions.”